Vascular medicine and thrombectomy in stroke
The treatment of stroke caused by intracranial vessel occlusion with intravenous recombinant tissue plasminogen activator (rt-PA) was the only evidence-based treatment option for a long time. Nevertheless the response rate was disappointing in large vessel occlusions. Five studies that evaluated the...
Main Authors: | Sebastian Fischer, Werner Weber |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2018-01-01
|
Series: | Therapeutic Advances in Neurological Disorders |
Online Access: | https://doi.org/10.1177/1756285617742082 |
Similar Items
-
Thrombectomy in Childhood Stroke
by: Peter B. Sporns, et al.
Published: (2019-03-01) -
Vascular tortuosity in endovascular mechanical thrombectomy
by: Jeffrey Farooq, et al.
Published: (2021-01-01) -
Mechanical thrombectomy for reperfusion of acute ischemic stroke in a Stroke Unit in Argentina
by: Matías ALET, et al.
Published: (2020-01-01) -
Outcome and periprocedural time management in referred directly admitted stroke patients treated with thrombectomy
by: Ralph Weber, et al.
Published: (2016-03-01) -
Letter to the Editor: Analysis of stroke patient migration for mechanical thrombectomy and changes in neurointerventional center size in Germany
by: Ralph Weber, et al.
Published: (2021-06-01)